Top-Line Data Readout From the Single Ascending Dose Part 1 Expected in the Third Quarter of 2024, and From the Multiple Ascending Dose Part 2 in the First Quarter of 2025 Planned Part 3 Will Assess ...
(RTTNews) - InflaRx N.V. (IFRX) Thursday announced positive results from the multiple ascending dose or MAD part of Phase I trial for INF904, an orally administered low molecular weight C5aR inhibitor ...
Streaming platforms for Mad God: Part 1 haven’t been announced yet. Check back soon for updates on where you can watch it online.
On April 22, 2025, MetaVia Inc. (NASDAQ:MTVA) announced additional positive topline results from the multiple ascending dose (MAD) Part 2 of the Phase 1 clinical trial of DA-1726 in obesity. The ...
On September 30, 2024, NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) announced positive topline results for the single ascending dose (SAD) Part 1 of the ongoing Phase 1 clinical trial of DA-1726 for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results